Besides the HDDW article you can also read the HDSA November 24, 2008 News
Release on Xenazine Tablets Availabile in the U.S. here www.hdsa.org/xenazine
where you'll also learn about how you can participate in a webcast to be hosted
on Wednesday, December 3rd at 12 PM eastern time conducted by Ovation and HDSA
to discuss Xenazine.

Click here http://www.hdsa.org/images/content/1/1/11586.pdf to view Ovation's
invitation. If you can't read PDF documents the invitation reads:

Please Join Us for an Informational Web Cast and Q&A on Xenazine*
(tetrabenazine) Tablets

When: Wednesday, December 3rd, 2008
Time: One Hour Live web cast with presentation and Q&A to begin at 12:00 p.m.
ET
Where: To view and listen** to the web cast, please visit
http://media.xfactorcom.com/XenazineInformation/20081203/
The link will become live 5 minutes before the web cast begins

Password: Please enter password Xenazine2008 when prompted

Featured panelists include:
Dave Knocke, Executive Director of Marketing, Movement Disorders Business
Unit, Ovation Pharmaceuticals
Barbara Boyle, National Executive Director & CEO, HDSA
Deb Lovecky, Director of Education Programs & Services, HDSA
Eric Pappert, MD, Neurologist

Please contact jlcarlson@... with questions

*Xenazine is a registered trademark of Cambridge Laboratories (Ireland) Limited.
** Limited phone lines are available for those who cannot access the web cast.
Please contact (202) 621-2886 for information on how to access via phone.

[Non-text portions of this message have been removed]